Article Information
History
- July 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Thitiporn Jaruthien1,2,
- Chonnipa Nantavithya1,2,
- Sakun Santisukwongchote3,
- Shanop Shuangshoti3,
- Piti Techavichit4,
- Darintr Sosothikul4,
- Jiraporn Amornfa5 and
- Kanjana Shotelersuk1,2,*
- 1Division of Therapeutic Radiology and Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
- 2Division of Therapeutic Radiology and Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 3Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 4Division of Hematology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 5Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- ↵*Corresponding author E-mail: kanjana.s{at}chula.ac.th
Posted July 10, 2022.
Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma
